Ablexis

Acquired

Home - Ablexis Ablexis A superior, next generation transgenic mouse platform for the discovery of therapeutic antibodies

San Diego, United States · Founded 2009 · $12.0M raised

Founded
2009
Business Model
B2B
Total Funding
$12.0M
Last Round
$12.0M Series AJun 2010
Rounds
1
Acquisition Date
Jun 2018

About

Founded in 2009, Ablexis is a biotechnology company that created the AlivaMab Mouse, a best-in-class transgenic mouse platform used by pharmaceutical and biotech partners to discover and develop human therapeutic antibodies. The company was built on technology developed at Aliva Biopharmaceuticals and is led by CEO Larry, a co-inventor of the XenoMouse technology with over 25 years of experience in transgenic antibody discovery. Ablexis licenses its AlivaMab Mouse platform to biopharmaceutical partners, with collaborations spanning major pharma companies such as Amgen, AstraZeneca, and Pfizer.

Summary

Ablexis is a Biotech company based in San Diego, United States, founded in 2009. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Jun 2010. Investors include Deerfield Management, Third Rock Ventures and Pfizer Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionJun 2018

Sign up to see all 2 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ablexis on Indexed.vc
<a href="https://indexed.vc/companies/ablexis"><img src="https://indexed.vc/api/badge/company/ablexis" alt="Ablexis on Indexed.vc" width="260" height="76" /></a>